Courtney Marabella

Articles

Sacituzumab govitecan-hziy improves quality of life in patients with metastatic triple-negative breast cancer

October 06, 2021

Sacituzumab govitecan-hziy resulted in a statistically significant and clinically meaningful improvement in health-related quality of life compared with single-agent chemotherapy of physician’s choice in patients with metastatic triple-negative breast cancer.